1
|
Kumar R, Kumar V, Kamal R, Kumar A, Kaur S, Bansal A, Chetti P. 2,4‐Bis(2‐(
E
)‐arylidenehydrazinyl)quinazolines: Expeditious Synthesis, Characterization, Antiproliferative Effects against Breast Cancer Cell Line and Molecular Docking Studies. ChemistrySelect 2022. [DOI: 10.1002/slct.202202635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Ravinder Kumar
- Department of Chemistry Kurukshetra University Kurukshetra, Kurukshetra 136119 Haryana INDIA
- Current Address: Department of Chemistry M. M. Engineering College Maharishi Markandeshwar (Deemed to be University) Mullana Ambala 133207 Haryana INDIA
| | - Vipan Kumar
- Department of Chemistry Kurukshetra University Kurukshetra, Kurukshetra 136119 Haryana INDIA
- Current Address: Department of Chemistry & MAP Section Department of Genetics and Plant Breeding CCS Haryana Agriculture University Hisar 125004 Haryana INDIA
| | - Raj Kamal
- Department of Chemistry Kurukshetra University Kurukshetra, Kurukshetra 136119 Haryana INDIA
| | - Ajay Kumar
- Department of Botanical & Environmental Sciences Guru Nanak Dev University Amritsar 143005 Punjab INDIA
| | - Satwinderjeet Kaur
- Department of Botanical & Environmental Sciences Guru Nanak Dev University Amritsar 143005 Punjab INDIA
| | - Arubhi Bansal
- Department of Chemistry National Institute of Technology (NIT) Kurukshetra 136119 Haryana INDIA
| | - Prabhakar Chetti
- Department of Chemistry National Institute of Technology (NIT) Kurukshetra 136119 Haryana INDIA
| |
Collapse
|
2
|
Husain A, Bhutani M, Parveen S, Khan SA, Ahmad A, Iqbal MA. Design, Synthesis, In Vitro Cytotoxicity, ADME Prediction, and Molecular Docking Study of Benzimidazole-Linked Pyrrolone and N-Benzylpyrrolone Derivatives. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY 2022. [DOI: 10.1134/s1070428022100098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
3
|
Pathak A, Pandey V, Raj Pokharel Y, Devaraji V, Ali A, Haider K, Saad S, Dewangan RP, Siddiqui N, Shahar Yar M. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents. Bioorg Chem 2021; 116:105358. [PMID: 34544029 DOI: 10.1016/j.bioorg.2021.105358] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2021] [Revised: 09/07/2021] [Accepted: 09/12/2021] [Indexed: 11/18/2022]
Abstract
Dual TK inhibitors have shown significant clinical effects against many tumors, but with unmanageable side effects. Design approach and selectivity of these inhibitors plays substantial role in their potency and side-effects. Understanding the homology of binding sites in targeted receptors, and involvement of signaling proteins after the inhibition might help in producing less toxic but effective inhibitors. Herein, we designed benzylideneindolon-2-one derivatives based on homology modeling in binding sites of VEGFR-2 and EGFR receptors as dual- inhibitor potent anticancer compounds with high selectivity. The benzylideneindolon-2-one derivatives were found to possess conformational switch in form of oxindole, substituted at 2-benzimidazole. Within synthesized compounds, 5b was found most active in in-vitro enzyme inhibition assay against VEGFR-2 and EGFR with highest IC50 value of 6.81 ± 2.55 and 13.04 ± 4.07 nM, respectively. Interestingly, cytotoxicity studies revealed selective toxicity of compound 5b against proliferation of A-431 cell lines (over expressed VEGFR-2 and EGFR) with GI50 value of 0.9 ± 0.66 µM. However, the compounds showed mild to moderate activity in all other cancer cell line in the range of 0.2-100 μM. Further mode of action studies by flow cytometry and western blot on A-431 indicated that they work via apoptosis at S- phase following Bcl/Bax pathway, and cell migration via MMP9. 5b not only suppressed tumor growth but also improved vandetanib associated with weight loss toxicity. Moreover, 5b was found safer than sunitinib and erlotinib with LD50 of 500 mg/kg body weight. These results propose 5b as potential anti-tumor drug with safer profile of conventional inhibitors of VEGFR-2 and EGFR for solid tumors.
Collapse
Affiliation(s)
- Ankita Pathak
- Department of Pharmaceutical Chemistry, SPER, Jamia Hamdard, Hamdard Nagar, New Delhi, India
| | - Vivek Pandey
- Faculty of Life Science and Biotechnology, South Asian University, New Delhi, India
| | - Yuba Raj Pokharel
- Faculty of Life Science and Biotechnology, South Asian University, New Delhi, India
| | - Vinod Devaraji
- Computational Drug Design Lab, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India
| | - Abuzer Ali
- Department of Pharmacognosy, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
| | - Kashif Haider
- Department of Pharmaceutical Chemistry, SPER, Jamia Hamdard, Hamdard Nagar, New Delhi, India
| | - Suma Saad
- Department of Pharmaceutics, SPER, Jamia Hamdard, Hamdard Nagar, New Delhi, India
| | | | - Nadeem Siddiqui
- Department of Pharmaceutical Chemistry, SPER, Jamia Hamdard, Hamdard Nagar, New Delhi, India
| | - M Shahar Yar
- Department of Pharmaceutical Chemistry, SPER, Jamia Hamdard, Hamdard Nagar, New Delhi, India.
| |
Collapse
|
4
|
Mary YS, Mary YS, Rad AS, Yadav R, Celik I, Sarala S. Theoretical investigation on the reactive and interaction properties of sorafenib – DFT, AIM, spectroscopic and Hirshfeld analysis, docking and dynamics simulation. J Mol Liq 2021. [DOI: 10.1016/j.molliq.2021.115652] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
5
|
Sroor FM, Abdelmoniem AM, Abdelhamid IA. Facile Synthesis, Structural Activity Relationship, Molecular Modeling and In Vitro Biological Evaluation of New Urea Derivatives with Incorporated Isoxazole and Thiazole Moieties as Anticancer Agents. ChemistrySelect 2019. [DOI: 10.1002/slct.201901415] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Farid M. Sroor
- Organometallic and Organometalloid Chemistry DepartmentNational Research Centre 12622 Cairo Egypt
| | | | | |
Collapse
|
6
|
The significance of N-methylpicolinamides in the development of anticancer therapeutics: Synthesis and structure-activity relationship (SAR) studies. Bioorg Chem 2019; 86:513-537. [DOI: 10.1016/j.bioorg.2019.02.030] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2018] [Revised: 02/02/2019] [Accepted: 02/12/2019] [Indexed: 01/30/2023]
|
7
|
Liu J, Liu Y, Hao X, Wang Y, Ji J, Liu Y, Ding S, Chen Y. Design, synthesis, and biological evaluation of novel 4‐phenoxypyridine derivatives as potential antitumor agents. Arch Pharm (Weinheim) 2019; 352:e1800338. [DOI: 10.1002/ardp.201800338] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2018] [Revised: 01/21/2019] [Accepted: 01/28/2019] [Indexed: 01/07/2023]
Affiliation(s)
- Ju Liu
- Key Laboratory of New Drug Research and Development of Liaoning ProvinceCollege of Pharmacy Liaoning UniversityShenyang P. R. China
| | - Yutong Liu
- Key Laboratory of New Drug Research and Development of Liaoning ProvinceCollege of Pharmacy Liaoning UniversityShenyang P. R. China
| | - Xuechen Hao
- Key Laboratory of New Drug Research and Development of Liaoning ProvinceCollege of Pharmacy Liaoning UniversityShenyang P. R. China
| | - Yang Wang
- Key Laboratory of New Drug Research and Development of Liaoning ProvinceCollege of Pharmacy Liaoning UniversityShenyang P. R. China
| | - Jingchao Ji
- Key Laboratory of New Drug Research and Development of Liaoning ProvinceCollege of Pharmacy Liaoning UniversityShenyang P. R. China
| | - Yajing Liu
- Key Laboratory of Structure‐Based Drug Design and Discovery of Ministry of EducationCollege of Pharmaceutical Engineering of Shenyang Pharmaceutical UniversityShenyang P. R. China
| | - Shi Ding
- Key Laboratory of New Drug Research and Development of Liaoning ProvinceCollege of Pharmacy Liaoning UniversityShenyang P. R. China
| | - Ye Chen
- Key Laboratory of New Drug Research and Development of Liaoning ProvinceCollege of Pharmacy Liaoning UniversityShenyang P. R. China
| |
Collapse
|
8
|
Synthesis and Antitumor Activity of Triazole-Containing Sorafenib Analogs. Molecules 2017; 22:molecules22101759. [PMID: 29064424 PMCID: PMC6151694 DOI: 10.3390/molecules22101759] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Revised: 10/13/2017] [Accepted: 10/15/2017] [Indexed: 01/07/2023] Open
Abstract
Using a highly effective binuclear Cu complex as the catalyst, the 1,3-dipolar cycloaddition reactions between 16 alkynes and two azides were successfully performed and resulted in the production of 25 new triazole-containing sorafenib analogs. Several compounds were evaluated as potent antitumor agents. Among them, 4-(4-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)phenoxy)-N-methylpicolinamide (8f) potently suppressed the proliferation of HT-29 cancer cells by inducing apoptosis and almost completely inhibited colony formation at a low micromolar concentration.
Collapse
|
9
|
Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold. Bioorg Med Chem 2017; 25:5754-5763. [DOI: 10.1016/j.bmc.2017.09.003] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2017] [Revised: 08/29/2017] [Accepted: 09/04/2017] [Indexed: 11/24/2022]
|